Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis.

• Main Authors: Yashpal S Chhonker (Author), Catherine Bjerum (Author), Veenu Bala (Author), Allassane F Ouattara (Author), Benjamin G Koudou (Author), Toki P Gabo (Author), Abdullah Alshehri (Author), Abdoulaye Meïté (Author), Peter U Fischer (Author), Gary J Weil (Author), Christopher L King (Author), Philip J Budge (Author), Daryl J Murry (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2023-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Moxidectin (MOX) is a milbemycin endectocide recently approved by the U.S. FDA for the treatment of onchocerciasis in persons at least 12 years of age. MOX has been shown to have a good safety profile in recent clinical trials. The efficacy of MOX for the treatment of lymphatic filariasis (LF) and i...